Industry News
Ipilimumab in advanced melanoma: added benefit for non-pretreated patients not proven
Mar 21, 2014
The German Institute for Quality and Efficiency in Health Care (IQWiG) already assessed the added benefit of ipilimumab in advanced melanoma in 2012. A considerable added benefit was found for patients who had already received previous treatment. Read More
Highly accurate noninvasive colorectal cancer screening tool
Mar 21, 2014
An Indiana University and Regenstrief Institute study of nearly 10,000 average-risk, asymptomatic men and women from 90 sites across the United States reports that a multi-target stool DNA test - a new noninvasive colorectal cancer screening tool that has not yet been approved for sale by the Food and Drug Administration - detects 92.3 percent of colon cancers, compared to only 73. Read More
Breast cancer: lack of resources in low-income countries 'alarming'
Mar 21, 2014
A presentation to be held at the 9th European Breast Cancer Conference today will reveal the latest figures that provide insight into the global burden of breast cancer. And although there are some signs of positivity in reducing this burden, it is clear there is still a lot more work to be done.According to Prof. Read More
Using nano-flares to measure genetic content in live cells to catch the early spread of breast cancer
Mar 21, 2014
When cancer spreads from one part of the body to another, it becomes even more deadly. It moves with stealth and can go undetected for months or years. But a new technology that uses "nano-flares" has the potential to catch these lurking, mobilized tumor cells early on. Read More
How localized bacterial infections can turn into dangerous sepsis
Mar 20, 2014
We carry numerous bacteria on our skin, in our mouth, gut, and other tissues, and localized bacterial infections are common and mostly not harmful. Occasionally, however, a localized infection turns into dangerous systemic disease (sepsis), and scientists have new clues as to how that happens. Read More
New type of cell communication regulates blood vessel formation and tumour growth
Mar 20, 2014
When tumours grow, new blood vessels are formed that deliver oxygen and nutrients to the tumour cells. A research group at Uppsala University has discovered a new type of cell communication that results in suppressed blood vessel formation and delayed tumour growth. Read More
NICE recommends Giotrif (afatinib) for first line treatment of EGFR mutation positive advanced lung cancer
Mar 20, 2014
Lung cancer patients in the UK are closer to gaining access to a new targeted treatment Giotrif® (afatinib), the first oncology treatment to be developed by Boehringer Ingelheim. Read More
101 liver cancer drug candidates pave the way to personalized medicine
Mar 20, 2014
The heart disease drug perhexiline is one of 101 compounds predicted to prevent cancer growth in most patients suffering from our most common liver cancer, HCC. This is an outcome from a novel simulation-based approach using personal sets of proteins of six HCC patients. Read More
Inflammatory feedback loop promotes colorectal cancer metastasis
Mar 20, 2014
Induction of the epithelial-mesenchymal transition (EMT) in cancer cells is associated with an increased capacity to invade into surrounding tissue and migrate to distant sites. The tumor-specific factors that drive EMT aren't completely understood; however, evidence implicates inflammation in this process. Read More
Major breakthrough in developing new cancer drugs: Capturing leukemic stem cells
Mar 20, 2014
The Institute for Research in Immunology and Cancer (IRIC) at the Université de Montréal (UdeM), in collaboration with the Maisonneuve-Rosemont Hospital's Quebec Leukemia Cell Bank, recently achieved a significant breakthrough thanks to the laboratory growth of leukemic stem cells, which will speed up the development of new cancer drugs. Read More
Previous Page Next Page